Fluconazole Tablets

Pre-Solicitation Posted

Not the latest version. See the latest solicitation from .

Solicitation number
SPE2D2-25-R-0009
Agency
Responses due
Not on record
Set-aside
No set-aside

Opportunity facts

Notice details come from SAM.gov. Updated .

About this opportunity

The Defense Logistics Agency Troop Support Medical is preparing to issue a solicitation for a national requirements contract for Fluconazole Tablets across multiple dosage strengths, including 50 MG, 100 MG, 150 MG, and 200 MG in various bottle and unit dose pack configurations. This will be a fully competitive, unrestricted acquisition using FAR part 12 for commercial items, with all sources eligible to submit proposals. The contract will be a firm-fixed price requirements type contract, establishing a national supply source for Department of Defense, Bureau of Prisons, Indian Health Service, and Department of Veterans Affairs customers through DLA and VA prime vendor programs. Interested parties should contact Courtney Hunter-Stangler at Courtney.Hunter-Stangler@dla.mil for questions, and are advised to set up automated notifications through DIBBS and SAM.gov. The projected solicitation date is April 2024, though DLA reserves the right to adjust this timeline.

The contract will have a one-year base period with four additional one-year option periods, targeting pharmaceutical manufacturers in the NAICS 325412 category for Pharmaceutical Preparation Manufacturing. While no specific set-aside designations are indicated, the solicitation will be fully competitive and open to all qualified sources. Annual usage estimates will be provided in the Schedule of Supplies section of the forthcoming solicitation, which will be posted on the DLA Bid Board System and SAM.gov. The contract will support multiple federal agencies' medical supply needs, covering Fluconazole Tablets in multiple dosage strengths and packaging configurations. Potential contractors should be prepared to provide comprehensive pharmaceutical supply capabilities across various federal healthcare systems, with the ability to meet stringent government procurement requirements and quality standards.

Notice text

The Defense Logistics Agency is planning to issue a solicitation for a national requirements contract for Fluconazole Tablets. Procurement details follow.

Fluconazole: 50 MG Tablets in 30 count bottles, 100 MG Tablets in 30 and 100 count bottles, 200 MG Tablets in 30 and 100 count bottles, and 150 MG Tablets in 12 count unit dose packs and 1 count bottles.

This will be an unrestricted and fully competitive acquisition. The contract will be a firm-fixed price, requirements type contract with a one-year base and four one-year options. A contract resulting from this solicitation will establish a national supply source, in accordance with FAR 52.216-21 (Requirements), to provide the items listed in the schedule for purchase by Department of Defense, Bureau of Prisons, Indian Health Service, and Department of Veterans Affairs customers through the DLA and VA prime vendor programs. The annual usage estimates will be provided in the Schedule of Supplies section of the solicitation. This is a commercial item and will be solicited using FAR part 12. All sources may submit a proposal which shall be considered by the agency.  

A copy of the solicitation will be posted to the DLA Bid Board System (DIBBS) at https://www.dibbs.bsm.dla.mil and SAM.gov at https://sam.gov. Interested parties should contact Courtney Hunter-Stangler at Courtney.Hunter-Stangler@dla.mil for any questions/comments. Interested parties are further advised to set up automated notifications of pre-solicitation or solicitation changes through this website. The current projected solicitation date is April of 2024. DLA reserves the right to issue the solicitation before or after the projected solicitation date.

Notice history

Notice Type Posted
Fluconazole Tablets Latest solicitation Solicitation
This notice Original Pre-Solicitation

Similar open opportunities

Opportunity Agency Set-aside Responses due
6505--Imatinib Tablets NAICS 325412 National Acquisition Center No set-aside
Methylphenidate ER NAICS 325412 Medical Supply Chain No set-aside

On GovTribe

Work this opportunity

  • Track it in your pipeline
  • Find teaming partners
  • Similar opportunities
  • Ask GovTribe AI about this opportunity